UNSPSC 85773304: Supplement right hand with nonautologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right hand with nonautologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0XUJ4KZ

UNSPSC 85773304 Supplement right hand with nonautologous tissue substitute, percutaneous endoscopic approach is a Commodity code with little relevant recent state and local procurement activity. The code's nominal scope—surgical tissue supplementation procedures—does not align with the recent opportunities posted under this classification. Recent solicitations tagged to this code concern occupational medical surveillance, pharmacy benefit management, disability pension evaluations, surgical benefit carve-out programs, youth detention healthcare services, and temporary health professional staffing—none of which involve tissue substitutes or the surgical procedures the code describes. The mismatch suggests either a data classification error in the underlying procurement systems or a systematic misalignment between the UNSPSC taxonomy and how state and local agencies are coding their medical and health-services purchases.

The issuing bodies posting under this code span state health systems, county governments, municipal pension offices, and county human services agencies across Arizona, California, Florida, and Washington, with no single jurisdiction appearing as a repeat buyer. The geographic distribution is dispersed, and the recent opportunities reflect routine procurement of clinical services—medical evaluations, pharmacy administration, occupational health screening, and staffing—rather than the specialized surgical procedure category the code nominally represents. Business development professionals should treat this code as having minimal relevance to tissue-substitute or surgical-supplement product sales, and instead examine whether their solutions align with the actual medical administration and clinical staffing services that state and local health purchasers are currently buying.